Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.

Hanrath, Aidan T; Payne, Brendan A I; Duncan, Christopher J A

Hanrath, Aidan T; Payne, Brendan A I; Duncan, Christopher J A.

Hanrath AT; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Payne BAI; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United KingdomThe Newcastle Hospitals HCW Testing Group(1).
Duncan CJA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United KingdomThe Newcastle Hospitals HCW Testing Group(1). Electronic address: christopher.duncan@newcastle.ac.uk.

J Infect ; 82(4): e29-e30, 2021 04.

Article in English | MEDLINE | ID: covidwho-1386022

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Health Personnel; Humans; Reinfection

Keywords

Antibody; COVID-19; Healthcare workers; Immunity; Protection

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: J Infect Year: 2021 Document Type: Article Affiliation country: J.JINF.2020.12.023

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google